Our re rating maybe coming:
https://-----head.com.au/health/fundie-merchant-group-picks-four-biotech-stocks-that-could-rip-as-sector-hits-rude-health-again/?utm_medium=email&utm_campaign=Lunchtime%20-02-19-2024&utm_content=httpsstockheadcomauhealthfundiemerchantgrouppicksfourbiotechstocksthatcouldripassectorhitsrudehealthagain&utm_medium=email&utm_campaign=Morning%20email%20Tuesday%20February%2020&utm_content=Morning%20email%20Tuesday%20February%2020+CID_23378f0f9a14c792585ffce5ff9a2003&utm_source=Campaign%20Monitor&utm_term=Fundie%20Merchant%20Group%20picks%20four%20biotech%20stocks%20that%20could%20rip%20as%20sector%20hits%20rude%20health%20again
Replace ----= with Stock
- Forums
- ASX - By Stock
- Significant Re Rating $80 to $800m
Our re rating maybe...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.32M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 7.5¢ | $18.49K | 244.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 96411 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 454970 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 96411 | 0.075 |
2 | 170000 | 0.074 |
2 | 139500 | 0.073 |
3 | 72231 | 0.072 |
4 | 87200 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 34069 | 1 |
0.080 | 94270 | 2 |
0.081 | 41839 | 2 |
0.082 | 85000 | 1 |
0.085 | 20503 | 1 |
Last trade - 10.28am 24/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online